Effect of Citiculin on Cognitive Complications in Bipolar Patients in manic episode Receiving Electroconvulsive
Phase 2
Recruiting
- Conditions
- Bipolar Disorder, current episode manic severe with psychotic features.Bipolar Disorder, current episode manic severe with psychotic featuresF31.2
- Registration Number
- IRCT20160523028008N9
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Bipolar patients in the acute phase of mania who, according to the physician, needed ECT
Young Mania Rating Scale greater than or equal to 20
Age greater than or equal to 18
Exclusion Criteria
Psychiatric disorders except Bipolar 1 Disorder
Having a systemic disease
Citicolin Contraindication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function. Timepoint: Before the intervention, after the first, second, third and fifth sessions of ECT. Method of measurement: Cognitive function Test by using Minimal Mental State Exam (MMSE).
- Secondary Outcome Measures
Name Time Method The reduction of mania symptoms. Timepoint: At the start of the study and the first and second week after receiving citicolin. Method of measurement: Young Mania Rating Scale (YMRS).